Company Ampliphi Biosciences Corp Nyse
Equities
APHB
US03211P2020
Biotechnology & Medical Research
Business description: Ampliphi Biosciences Corp
Sales by Activity: Ampliphi Biosciences Corp
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Biotechnology | - | 823K | 4.47M | 5.51M | 4.53M |
Geographical breakdown of sales: Ampliphi Biosciences Corp
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
United States | - | 823K | 4.47M | 5.51M | 4.53M |
Managers: Ampliphi Biosciences Corp
Director | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 69 | 2023-07-10 |
David House
DFI | Director of Finance/CFO | 41 | 2024-08-15 |
Peter Hubbard
COO | Chief Operating Officer | - | - |
Pierre Kyme
PRN | Corporate Officer/Principal | - | - |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Members of the board: Ampliphi Biosciences Corp
Manager | Title | Age | Since |
---|---|---|---|
Joseph Patti
BRD | Director/Board Member | 61 | 2019-05-08 |
Todd Peterson
BRD | Director/Board Member | 67 | 2019-10-09 |
Director/Board Member | 65 | 2020-02-11 | |
Odysseas Kostas
BRD | Director/Board Member | 50 | 2020-02-11 |
Robin Kramer
CHM | Chairman | 59 | - |
Jules Haimovitz
CHM | Chairman | 74 | 2021-05-31 |
Deborah Birx
BRD | Director/Board Member | 69 | 2023-07-10 |
Company details: Ampliphi Biosciences Corp

Bio Therapeutic Drugs
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-0.77% | -2.20% | +9.84% | +98.50% | 118B | ||
-0.10% | -5.13% | -28.93% | +8.03% | 72.09B | ||
-2.13% | -3.83% | +68.23% | +140.90% | 38.79B | ||
-2.40% | +1.89% | +31.02% | -22.46% | 28.73B | ||
+2.38% | +3.29% | +58.26% | +12.45% | 24.63B | ||
+4.61% | +2.25% | +11.97% | -30.27% | 23.61B | ||
-2.06% | +6.27% | +380.22% | +952.71% | 15.76B | ||
+0.81% | -0.80% | +189.03% | +244.83% | 14.19B | ||
+0.94% | +8.59% | -19.89% | -31.61% | 13.46B | ||
Average | +0.14% | +1.06% | +77.75% | +152.57% | 38.79B | |
Weighted average by Cap. | -0.26% | -1.16% | +36.48% | +99.29% |